Search details
1.
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
J Antimicrob Chemother
; 79(5): 1006-1013, 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38497988
2.
Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
J Antimicrob Chemother
; 79(5): 1081-1092, 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38517452
3.
Clinic-based evaluation of the dual Xpert CT/NG assay on the GeneXpert System for screening for extragenital chlamydial and gonococcal infections amongst men who have sex with men.
BMC Infect Dis
; 24(Suppl 1): 224, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38418963
4.
Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa.
BMC Infect Dis
; 24(Suppl 1): 277, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38438953
5.
High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae.
J Antimicrob Chemother
; 78(7): 1769-1778, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37253051
6.
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
J Antimicrob Chemother
; 78(8): 1982-1991, 2023 08 02.
Article
in English
| MEDLINE | ID: mdl-37352017
7.
Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022.
Euro Surveill
; 28(10)2023 03.
Article
in English
| MEDLINE | ID: mdl-36892469
8.
A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae.
Antimicrob Agents Chemother
; 66(5): e0025122, 2022 05 17.
Article
in English
| MEDLINE | ID: mdl-35465683
9.
Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
J Antimicrob Chemother
; 77(8): 2171-2182, 2022 07 28.
Article
in English
| MEDLINE | ID: mdl-35542983
10.
GyrB in silico mining in 27â151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.
J Antimicrob Chemother
; 78(1): 150-154, 2022 12 23.
Article
in English
| MEDLINE | ID: mdl-36308328
11.
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
Sex Transm Dis
; 49(4): 251-256, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34772893
12.
Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022.
Euro Surveill
; 27(24)2022 06.
Article
in English
| MEDLINE | ID: mdl-35713023
13.
Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022.
Euro Surveill
; 27(50)2022 12.
Article
in English
| MEDLINE | ID: mdl-36695466
14.
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005-2019.
Emerg Infect Dis
; 27(9): 2369-2378, 2021.
Article
in English
| MEDLINE | ID: mdl-34424175
15.
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
J Antimicrob Chemother
; 76(4): 940-944, 2021 03 12.
Article
in English
| MEDLINE | ID: mdl-33411920
16.
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
J Antimicrob Chemother
; 76(1): 84-90, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32929456
17.
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
J Antimicrob Chemother
; 76(5): 1221-1228, 2021 04 13.
Article
in English
| MEDLINE | ID: mdl-33564854
18.
Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
BMC Infect Dis
; 21(1): 559, 2021 Jun 12.
Article
in English
| MEDLINE | ID: mdl-34118893
19.
Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
BMC Infect Dis
; 21(1): 520, 2021 Jun 02.
Article
in English
| MEDLINE | ID: mdl-34078300
20.
Chlamydia trachomatis in Iceland: Prevalence, Clinico-epidemiological Features and Comparison of Cobas 480 CT/NG and Aptima Combo 2 (CT/NG) for Diagnosis.
Acta Derm Venereol
; 101(2): adv00393, 2021 Feb 11.
Article
in English
| MEDLINE | ID: mdl-33554267